Pre-Tax Income: Company's earnings or loss before taxes on income have been accounted for.
Bora Pharmaceuticals Co., Ltd. - Sponsored ADR (BORAY) had Pre-Tax Income of $29.73M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$155.45M |
|
$11.96M |
|
$98.98M |
|
$56.47M |
|
$138.21M |
|
$17.24M |
|
$12.50M |
|
|
Pre-Tax Income |
$29.73M |
$29.73M |
|
$17.16M |
|
$17.16M |
|
$13.03M |
|
$17.16M |
|
$17.24M |
|
$24.75M |
|
623.78M |
|
678.68M |
|
$-0.00 |
|
$0.00 |
|
| Balance Sheet Financials | |
$620.74M |
|
$334.91M |
|
$814.59M |
|
$1.44B |
|
$427.60M |
|
$378.66M |
|
$446.87M |
|
$874.47M |
|
$560.86M |
|
$360.41M |
|
$560.86M |
|
634.94M |
|
| Cash Flow Statement Financials | |
$144.57M |
|
$-108.49M |
|
$-44.20M |
|
$187.12M |
|
$162.97M |
|
$-24.15M |
|
$2.52M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.45 |
|
-- |
|
-- |
|
0.40 |
|
1.00 |
|
36.33% |
|
11.09% |
|
11.09% |
|
-- |
|
19.13% |
|
7.69% |
|
$123.30M |
|
-- |
|
-- |
|
-- |
|
0.11 |
|
0.90 |
|
0.53 |
|
169.77 |
|
3.06% |
|
4.76% |
|
1.20% |
|
1.83% |
|
$0.88 |
|
$0.18 |
|
$0.21 |
|